Recombineering: Genetic Engineering in Escherichia coli Using Homologous Recombination

Author:

Thomason Lynn C.1,Costantino Nina2,Li Xintian3,Court Donald L.4

Affiliation:

1. Molecular Control and Genetics Section, RNA Biology Laboratory, National Cancer Institute at Frederick National Institutes of Health Frederick Maryland

2. formerly with Molecular Control and Genetics Section, RNA Biology Laboratory, National Cancer Institute at Frederick National Institutes of Health Frederick Maryland

3. Armata Pharmaceuticals Marina del Rey California

4. Emeritus, Molecular Control and Genetics Section, RNA Biology Laboratory, National Cancer Institute at Frederick National Institutes of Health Frederick Maryland

Abstract

AbstractThe bacterial chromosome and bacterial plasmids can be engineered in vivo by homologous recombination using either PCR products or synthetic double‐stranded DNA (dsDNA) or single‐stranded DNA as substrates. Multiple linear dsDNA molecules can be assembled into an intact plasmid. The technology of recombineering is possible because bacteriophage‐encoded recombination proteins efficiently recombine sequences with homologies as short as 35 to 50 bases. Recombineering allows DNA sequences to be inserted or deleted without regard to the location of restriction sites and can also be used in combination with CRISPR/Cas targeting systems. © 2023 Wiley Periodicals LLC. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.Basic Protocol: Making electrocompetent cells and transforming with linear DNASupport Protocol 1: Selection/counter‐selections for genome engineeringSupport Protocol 2: Creating and screening for oligo recombinants by PCRSupport Protocol 3: Other methods of screening for unselected recombinantsSupport Protocol 4: Curing recombineering plasmids containing a temperature‐sensitive replication functionSupport Protocol 5: Removal of the prophage by recombineeringAlternate Protocol 1: Using CRISPR/Cas9 as a counter‐selection following recombineeringAlternate Protocol 2: Assembly of linear dsDNA fragments into functional plasmidsAlternate Protocol 3: Retrieval of alleles onto a plasmid by gap repairAlternate Protocol 4: Modifying multicopy plasmids with recombineeringSupport Protocol 6: Screening for unselected plasmid recombinantsAlternate Protocol 5: Recombineering with an intact λ prophageAlternate Protocol 6: Targeting an infecting λ phage with the defective prophage strains

Funder

National Cancer Institute

National Institutes of Health

Publisher

Wiley

Subject

Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3